Synonyms:
Status: Phase 3
Entry Type: Antibody
Molecule Category: UNKNOWN
ATC: L04AC15
UNII: 640443FU93

Pharmacology

Action Mechanism of Action Reference
INHIBITOR Interleukin-6 inhibitor PubMed

Indications

Mesh Heading Maximum Phase Mesh ID Reference
Arthritis, Rheumatoid 3 D001172 ClinicalTrials
Giant Cell Arteritis 3 D013700 ClinicalTrials
Polymyalgia Rheumatica 3 D011111 ClinicalTrials
Depressive Disorder, Major 2 D003865 ClinicalTrials
Severe Acute Respiratory Syndrome 2 D045169 ClinicalTrials
Asthma 2 D001249 ClinicalTrials
Lupus Nephritis 2 D008181 ClinicalTrials
Lupus Erythematosus, Systemic 1 D008180 ClinicalTrials
Lupus Erythematosus, Cutaneous 1 D008178 ClinicalTrials

Cross References

Resources Reference
CAS NUMBER 1194585-53-9
ChEMBL CHEMBL1743071
FDA SRS 640443FU93
Guide to Pharmacology 7989